Laboratorio Reig Jofre SA
F:FEQ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Laboratorio Reig Jofre SA
F:FEQ1
|
ES |
|
Cordel Group PLC
F:3EW
|
UK |
|
IMCD NV
AEX:IMCD
|
NL |
|
Cannabis Sativa Inc
OTC:CBDS
|
US |
|
G
|
Goodman Group
F:MY4
|
AU |
|
Bandai Namco Holdings Inc
OTC:NCBDY
|
JP |
|
A
|
Align Technology Inc
XBER:AFW
|
US |
|
S
|
Stericycle Inc
F:SY9
|
US |
|
F
|
Franchetti SpA
F:D0E
|
IT |
|
I
|
InterDigital Inc
SWB:IDI
|
US |
|
A
|
Aurubis AG
F:NDA
|
DE |
|
Voxtur Analytics Corp
OTC:VXTRF
|
CA |
|
KBC Groep NV
LSE:0EYG
|
BE |
|
L
|
Lucara Diamond Corp
XBER:LKT
|
CA |
|
L
|
Lucara Diamond Corp
STO:LUC
|
CA |
|
M
|
Matas A/S
F:1MTA
|
DK |
|
A
|
Ascot Resources Ltd
XMUN:BHQ
|
CA |
|
C
|
Charter Communications Inc
F:CQD
|
US |
Bankruptcy Probability
Laboratorio Reig Jofre SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Laboratorio Reig Jofre SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ES |
|
Laboratorio Reig Jofre SA
MAD:RJF
|
220.6m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
933.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
540B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
278.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
147.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Laboratorio Reig Jofre SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Laboratorio Reig Jofre SA has total debt of 58.5m EUR. This includes both short-term (0 EUR) and long-term (58.5m EUR) debt.
You can find a full breakdown on its Balance Sheet.
